Search research articles
Contact Us
Filters
Showing results (111-120 of 301) with videos related to
Page
of 31
Sort By:
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
September 24, 2009
The adoption of cost-effectiveness acceptability curves in cost-utility analyses
Lisa M Meckley, Dan Greenberg, Joshua T Cohen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 23, 2023
Has the Centers for Medicare & Medicaid Services Implicitly Adopted a Value Framework for Medicare Drug Price Negotiations?
Sean D Sullivan, Inmaculada Hernandez, Scott D Ramsey, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 31, 2020
Measuring "Fearonomic Effects" in Valuing Therapies: An Application to COVID-19 in China
Siyu Ma, David D Kim, Joshua T Cohen, et al.
Radiology
|
November 18, 2008
Twenty years of cost-effectiveness analysis in medical imaging: are we improving?
Hansel J Otero, Frank J Rybicki, Dan Greenberg, et al.
Medical Care
|
December 24, 2011
Factors predicting Medicare national coverage: an empirical analysis
James D Chambers, Stephen Morris, Peter J Neumann, et al.
The Milbank Quarterly
|
August 30, 2023
Improving Food and Drug Administration-Centers for Medicare and Medicaid Services Coordination for Drugs Granted Accelerated Approval
Peter J Neumann, Elliott Crummer, James D Chambers, et al.
BMJ Global Health
|
June 11, 2019
Taking stock of cost-effectiveness analysis of healthcare in China
Thomas Butt, Gordon G Liu, David D Kim, et al.
Health Affairs (Project Hope)
|
December 8, 2011
Risk-sharing arrangements that link payment for drugs to health outcomes are proving hard to implement
Peter J Neumann, James D Chambers, Françoise Simon, et al.
Annals of Internal Medicine
|
August 8, 2018
Risk-Targeted Lung Cancer Screening
Vaibhav Kumar, Joshua T Cohen, Peter J Neumann, et al.
Pharmacoeconomics
|
September 25, 2007
Valuing children's health: a comparison of cost-utility analyses for adult and paediatric health interventions in the US
Joseph A Ladapo, Peter J Neumann, Ron Keren, et al.
Page
of 31
Search research articles
Search
Showing results (111-120 of 301) with videos related to
Sort By:
Page
of 31
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
September 24, 2009
The adoption of cost-effectiveness acceptability curves in cost-utility analyses
Lisa M Meckley, Dan Greenberg, Joshua T Cohen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 23, 2023
Has the Centers for Medicare & Medicaid Services Implicitly Adopted a Value Framework for Medicare Drug Price Negotiations?
Sean D Sullivan, Inmaculada Hernandez, Scott D Ramsey, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 31, 2020
Measuring "Fearonomic Effects" in Valuing Therapies: An Application to COVID-19 in China
Siyu Ma, David D Kim, Joshua T Cohen, et al.
Radiology
|
November 18, 2008
Twenty years of cost-effectiveness analysis in medical imaging: are we improving?
Hansel J Otero, Frank J Rybicki, Dan Greenberg, et al.
Medical Care
|
December 24, 2011
Factors predicting Medicare national coverage: an empirical analysis
James D Chambers, Stephen Morris, Peter J Neumann, et al.
The Milbank Quarterly
|
August 30, 2023
Improving Food and Drug Administration-Centers for Medicare and Medicaid Services Coordination for Drugs Granted Accelerated Approval
Peter J Neumann, Elliott Crummer, James D Chambers, et al.
BMJ Global Health
|
June 11, 2019
Taking stock of cost-effectiveness analysis of healthcare in China
Thomas Butt, Gordon G Liu, David D Kim, et al.
Health Affairs (Project Hope)
|
December 8, 2011
Risk-sharing arrangements that link payment for drugs to health outcomes are proving hard to implement
Peter J Neumann, James D Chambers, Françoise Simon, et al.
Annals of Internal Medicine
|
August 8, 2018
Risk-Targeted Lung Cancer Screening
Vaibhav Kumar, Joshua T Cohen, Peter J Neumann, et al.
Pharmacoeconomics
|
September 25, 2007
Valuing children's health: a comparison of cost-utility analyses for adult and paediatric health interventions in the US
Joseph A Ladapo, Peter J Neumann, Ron Keren, et al.
Page
of 31